RESUMO
Increasing evidence suggests a role for excessive intake of fructose in the Western diet as a contributor to the current epidemics of metabolic syndrome and obesity. Hereditary fructose intolerance (HFI) is a difficult and potentially lethal orphan disease associated with impaired fructose metabolism. In HFI, the deficiency of aldolase B results in the accumulation of intracellular phosphorylated fructose, leading to phosphate sequestration and depletion, increased adenosine triphosphate (ATP) turnover, and a plethora of conditions that lead to clinical manifestations such as fatty liver, hyperuricemia, Fanconi syndrome, and severe hypoglycemia. Unfortunately, there is currently no treatment for HFI, and avoiding sugar and fructose has become challenging in our society. In this report, through use of genetically modified mice and pharmacological inhibitors, we demonstrate that the absence or inhibition of ketohexokinase (Khk), an enzyme upstream of aldolase B, is sufficient to prevent hypoglycemia and liver and intestinal injury associated with HFI. Herein we provide evidence for the first time to our knowledge of a potential therapeutic approach for HFI. Mechanistically, our studies suggest that it is the inhibition of the Khk C isoform, not the A isoform, that protects animals from HFI.
Assuntos
Frutoquinases/antagonistas & inibidores , Frutoquinases/metabolismo , Intolerância à Frutose/enzimologia , Animais , Frutoquinases/genética , Frutose/genética , Frutose/metabolismo , Intolerância à Frutose/tratamento farmacológico , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/antagonistas & inibidores , Frutose-Bifosfato Aldolase/genética , Frutose-Bifosfato Aldolase/metabolismo , Isoenzimas/antagonistas & inibidores , Isoenzimas/genética , Camundongos , Camundongos KnockoutRESUMO
We report a case with the association of well self-compensated hereditary fructose intolerance and still poorly symptomatic Duchenne type muscular dystrophy. This case illustrates the problems of a correct diagnosis in sub-clinical patients presenting with "cryptogenic" hypertransaminasemia.
Assuntos
Fígado Gorduroso/diagnóstico , Intolerância à Frutose/diagnóstico , Distrofia Muscular de Duchenne/diagnóstico , Transaminases/sangue , Pré-Escolar , Diagnóstico Diferencial , Fígado Gorduroso/enzimologia , Intolerância à Frutose/enzimologia , Humanos , Masculino , Distrofia Muscular de Duchenne/enzimologiaAssuntos
Intolerância à Frutose/diagnóstico , Frutose-Bifosfato Aldolase/deficiência , Frutose/metabolismo , Lisossomos/enzimologia , Transferrina/metabolismo , Dieta com Restrição de Carboidratos , Diagnóstico Precoce , Intolerância à Frutose/dietoterapia , Intolerância à Frutose/enzimologia , Frutose-Bifosfato Aldolase/genética , Humanos , Focalização Isoelétrica , Plasma , Isoformas de Proteínas/metabolismoRESUMO
Hereditary fructose intolerance (HFI) is a disease of carbohydrate metabolism that can result in hyperuricemia, hypoglycemia, liver and kidney failure, coma, and death. Currently, the only treatment for HFI is a strict fructose-free diet. HFI arises from aldolase B deficiency, and the most predominant HFI mutation is an alanine to proline substitution at position 149 (A149P). The resulting aldolase B with the A149P substitution (AP-aldolase) has activity that is <100-fold that of the wild type. The X-ray crystal structure of AP-aldolase at both 4 and 18 °C reveals disordered adjacent loops of the (α/ß)(8) fold centered around the substitution, which leads to a dimeric structure as opposed to the wild-type tetramer. The effects of osmolytes were tested for restoration of structure and function. An initial screen of osmolytes (glycerol, sucrose, polyethylene glycol, 2,4-methylpentanediol, glutamic acid, arginine, glycine, proline, betaine, sarcosine, and trimethylamine N-oxide) reveals that glycine, along with similarly structured compounds, betaine and sarcosine, protects AP-aldolase structure and activity from thermal inactivation. The concentration and functional moieties required for thermal protection show a zwitterion requirement. The effects of osmolytes in restoring structure and function of AP-aldolase are described. Testing of zwitterionic osmolytes of increasing size and decreasing fractional polar surface area suggests that osmolyte-mediated AP-aldolase stabilization occurs neither primarily through excluded volume effects nor through transfer free energy effects. These data suggest that AP-aldolase is stabilized by binding to the native structure, and they provide a foundation for developing stabilizing compounds for potential therapeutics for HFI.
Assuntos
Intolerância à Frutose/enzimologia , Frutose-Bifosfato Aldolase/química , Frutose-Bifosfato Aldolase/genética , Variação Genética , Mutação de Sentido Incorreto , Compostos Orgânicos/química , Estabilidade Enzimática , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/metabolismo , Humanos , Conformação ProteicaRESUMO
Hereditary fructose intolerance (HFI) is an autosomal recessive metabolic disease caused by impaired functioning of human liver aldolase (ALDOB). At least 54 subtle/point mutations and only two large intragenic deletions have been found in the ALDOB gene. Here we report two novel ALDOB variants (p.R46W and p.Y343H) and an intragenic deletion that we found in patients with suspected HFI. The residual catalytic activity of the recombinant p.R46W and p.Y343H variants toward F1P was particularly altered. We also characterized a large intragenic deletion that we found in six unrelated patients. This is the first report of six unrelated patients sharing the same ALDOB deletion, thus indicating a founder effect for this allele in our geographic area. Because this deletion involves ALDOB exon 5, it can mimic worldwide common pathogenic genotypes, that is, homozygous p.A150P and p.A175D. Finally, the identification of only one ALDOB mutation in symptomatic patients suggests that HFI symptoms can, albeit rarely, appear also in heterozygotes. Therefore, an excessive and continuous fructose dietary intake may have deleterious effects even in apparently asymptomatic HFI carriers.
Assuntos
Intolerância à Frutose/enzimologia , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Deleção de Genes , Alelos , Sequência de Bases , Criança , Dicroísmo Circular , Evolução Fatal , Feminino , Intolerância à Frutose/diagnóstico , Frutose-Bifosfato Aldolase/química , Frequência do Gene/genética , Humanos , Lactente , Itália , Cinética , Masculino , Dados de Sequência Molecular , Linhagem , Estrutura Secundária de Proteína , Proteínas Recombinantes/metabolismoRESUMO
BACKGROUND: Variable increases in the plasma activity of different lysosomal enzymes have been reported in patients with congenital disorders of glycosylation (CDG). In particular, elevated plasma aspartylglucosaminidase activity (AGA) has been found in the majority of CDG type I patients. We report on the plasma activity of AGA and other lysosomal enzymes in patients with different types of primary and secondary CDG defects. METHODS: AGA, alpha-mannosidase, beta-mannosidase and beta-hexosaminidase activities were assayed in the plasma of patients with CDGI (4CDGIa, 4CDGIx) and CDGIIx (5, all with a combined N- and O-glycosylation defect), classical galactosemia (GALT) (n=3) and hereditary fructose intolerance (HFI) (n=2). RESULTS: Increased AGA and beta-hexosaminidase activities were found in all and 7/8 of the GDGI patients respectively. All enzymic activities were normal in the CDGIIx patients. Elevated AGA and beta-hexosaminidase activity was also seen in GALT and HFI patients before treatment, when transferrin isoelectric focusing (TfIEF) patterns were also abnormal. CONCLUSIONS: Increased AGA plasma activity, although a consistent finding in CDGI patients, is not specific to this group of disorders since it is also observed in untreated cases of GALT and HFI. Furthermore, plasma AGA activity cannot serve as a marker for CDGII disorders. In conjunction with TfIEF it could be used in the follow up of GALT and HFI patients.
Assuntos
Aspartilglucosilaminase/sangue , Erros Inatos do Metabolismo da Frutose/enzimologia , Galactosemias/enzimologia , Adolescente , Criança , Pré-Escolar , Intolerância à Frutose/sangue , Intolerância à Frutose/diagnóstico , Intolerância à Frutose/enzimologia , Erros Inatos do Metabolismo da Frutose/sangue , Erros Inatos do Metabolismo da Frutose/diagnóstico , Galactosemias/sangue , Glicosilação , Humanos , Lactente , Lisossomos/enzimologia , alfa-Manosidase/sangue , beta-Manosidase/sangue , beta-N-Acetil-Hexosaminidases/sangueRESUMO
We investigated the molecular basis of hereditary fructose intolerance (HFI) in 160 patients from 92 families by means of a PCR-based mutation screening strategy, consisting of restriction enzyme digestion and direct sequencing. Sixteen different mutations of the aldolase B (ALDOB) gene were identified in HFI patients. As in previous studies, p.A150P (64%), p.A175D (16%) and p.N335K (5%) were the most common mutated alleles, followed by p.R60X, p.A338V, c.360_363delCAAA (p.N120KfsX30), c.324G>A (p.K108K) and c.625-1G>A. Eight novel mutations were also identified in 10 families with HFI: a one-base deletion (c.146delT (p.V49GfsX27)), a small deletion (c.953del42bp), a small insertion (c.689ins TGCTAA (p.K230MfsX136)), one splice site mutation (c.112+1G>A), one nonsense mutation (c.444G>A (p.W148X)), and three missense mutations (c.170G>C (p.R57P), c.839C>A (p.A280P) and c.932T>C (p.L311P)). Our strategy allows to diagnose 75% of HFI patients using restriction enzymatic analysis and to enlarge the diagnosis to 97% of HFI patients when associated with direct sequencing.
Assuntos
Intolerância à Frutose/enzimologia , Frutose-Bifosfato Aldolase/genética , Mutação , Adolescente , Adulto , Criança , Pré-Escolar , Cromossomos Humanos Par 9 , Estudos de Coortes , Análise Mutacional de DNA/métodos , Feminino , França , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/deficiência , Humanos , Lactente , Recém-Nascido , MasculinoRESUMO
BACKGROUND: The widespread use of routine biochemical assays has led to increased incidental findings of hypertransaminasemia. We aimed to evaluate the prevalence of different causes of raised aminotransferase levels in children referred to a university department of pediatrics. METHODS: We investigated 425 consecutive children (age range, 1-18 years) with isolated hypertransaminasemia. All patients had raised aminotransferase levels on at least two occasions in the last month before observation. Cases due to major hepatotropic viruses were excluded. RESULTS: During the first 6 months of observation, 259 children showed normalized liver enzymes. Among the remaining 166 patients with hypertransaminasemia lasting for more than 6 months, 75 had obesity-related liver disease; 51, genetic disorders; 7, autoimmune hepatitis; 5, cholelithiasis; 3, choledochal cyst; and 3, celiac disease. Among the 51 children with genetic disorders, 18 had Wilson disease; 14, muscular dystrophy; 4, alpha-1-antitrypsin deficiency; 4, Alagille syndrome; 4, hereditary fructose intolerance; 3, glycogen storage disease (glycogenosis IX); 2, ornithine transcarbamylase deficiency; and 2, Shwachman's syndrome. In 22 children, the hypertransaminasemia persisted for more than 6 months in the absence of a known cause. CONCLUSIONS: Genetic disease accounted for 12% of cases of isolated hypertransaminasemia observed in a tertiary pediatric department. A high level of suspicion is desirable for an early diagnosis of these disorders, which may present with isolated hypertransaminasemia and absence of typical clinical signs.
Assuntos
Biomarcadores/sangue , Hepatopatias/enzimologia , Hepatopatias/genética , Transaminases/sangue , Adolescente , Síndrome de Alagille/enzimologia , Criança , Pré-Escolar , Feminino , Intolerância à Frutose/enzimologia , Doenças Genéticas Inatas/complicações , Doença de Depósito de Glicogênio/enzimologia , Degeneração Hepatolenticular/enzimologia , Humanos , Lactente , Masculino , Distrofias Musculares/complicações , Doença da Deficiência de Ornitina Carbomoiltransferase/enzimologia , Deficiência de alfa 1-Antitripsina/enzimologiaRESUMO
We investigated the molecular basis of hereditary fructose intolerance (HFI) in 80 patients from 72 families by means of a PCR-based mutation screening strategy, consisting of heteroduplex analysis, restriction enzyme digest, DNA single strand electrophoresis, and direct sequencing. For a subset of patients mutation screening with DHPLC was established which turned out to be as fast and as sensitive as the more conventional methods. Fifteen different mutations of the aldolase B (ALDOB) gene were identified in HFI patients. As in smaller previous studies, p.A150P (65%), p.A175D (11%) and p.N335K (8%) were the most common mutated alleles, followed by c.360_363delCAAA, p.R60X, p.Y204X, and c.865delC. Eight novel mutations were identified in eight families with HFI: a small indel mutation (c.1044_1049delTTCTGGinsACACT), two small deletions (c.345_372del28; c.841_842delAC), two splice site mutations (c.113-1G>A, c.799+2T>A), one nonsense mutation (c.612T>G (p.Y204X)), and two missense mutations (c.532T>C (p.C178R), c.851T>C (p.L284P)). By mutation screening for the three most common ALDOB mutations by DHPLC in 2,000 randomly selected newborns we detected 21 heterozygotes. Based on these data and after correction for less common and private ALDOB mutations, HFI prevalence in central Europe is estimated to be 1:26,100 (95% confidence interval 1: 12,600-79,000).
Assuntos
Intolerância à Frutose/enzimologia , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Mutação/genética , Cromatografia Líquida de Alta Pressão , Análise Mutacional de DNA , Europa (Continente)/epidemiologia , Intolerância à Frutose/epidemiologia , Frequência do Gene , Genótipo , Humanos , Recém-Nascido , Triagem Neonatal , PrevalênciaRESUMO
Hereditary fructose intolerance (HFI) is a potentially lethal inborn error in metabolism caused by mutations in the aldolase B gene, which is critical for gluconeogenesis and fructose metabolism. The most common mutation, which accounts for 53% of HFI alleles identified worldwide, results in substitution of Pro for Ala at position 149. Structural and functional investigations of human aldolase B with the A149P substitution (AP-aldolase) have shown that the mutation leads to losses in thermal stability, quaternary structure, and activity. X-ray crystallography is used to reveal the structural basis of these perturbations. Crystals of AP-aldolase are grown at two temperatures (4 degrees C and 18 degrees C), and the structure solved to 3.0 angstroms resolution, using the wild-type structure as the phasing model. The structures reveal that the single residue substitution, A149P, causes molecular disorder around the site of mutation (residues 148-159), which is propagated to three adjacent beta-strand and loop regions (residues 110-129, 189-199, 235-242). Disorder in the 110-129-loop region, which comprises one subunit-subunit interface, provides an explanation for the disrupted quaternary structure and thermal instability. Greater structural perturbation, particularly at a Glu189-Arg148 salt bridge in the active-site architecture, is observed in the structure determined at 18 degrees C, which could explain the temperature-dependent loss in activity. The disorder revealed in these structures is far greater than that predicted by homology modeling and underscores the difficulties in predicting perturbations of protein structure and function by homology modeling alone. The AP-aldolase structure reveals the molecular basis of a hereditary disease and represents one of only a few structures known for mutant proteins at the root of the thousands of other inherited disorders.
Assuntos
Intolerância à Frutose , Frutose-Bifosfato Aldolase , Frutose/metabolismo , Mutação Puntual , Estrutura Quaternária de Proteína , Sítios de Ligação , Cristalografia por Raios X , Estabilidade Enzimática , Intolerância à Frutose/enzimologia , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/química , Frutose-Bifosfato Aldolase/genética , Frutose-Bifosfato Aldolase/metabolismo , Humanos , Modelos Moleculares , Estrutura Terciária de Proteína , TemperaturaRESUMO
Hereditary fructose intolerance (HFI) is a recessively inherited disorder of carbohydrate metabolism caused by impaired functioning of human liver aldolase (B isoform; ALDOB). To-date, 29 enzyme-impairing mutations have been identified in the aldolase B gene. Here we report six novel HFI single nucleotide changes identified by sequence analysis in the aldolase B gene. Three of these are missense mutations (g.6846T>C, g.10236G>T, g.10258T>C), one is a nonsense mutation (g.8187C>T) and two affect splicing sites (g.8180G>C and g.10196A>G). We have expressed in bacterial cells the recombinant proteins corresponding to the g.6846T>C (p.I74T), g.10236G>T (p.V222F), and g.10258T>C (p.L229P) natural mutants to study their effect on aldolase B function and structure. All the new variants were insoluble; molecular graphics data suggest this is due to impaired folding.
Assuntos
Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Mutação , Adulto , Alelos , Criança , Análise Mutacional de DNA , Feminino , Intolerância à Frutose/enzimologia , Humanos , ItáliaAssuntos
Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Sequência de Bases , DNA/química , DNA/genética , Análise Mutacional de DNA , Saúde da Família , Feminino , Intolerância à Frutose/enzimologia , Frutose-Bifosfato Aldolase/metabolismo , Frequência do Gene , Genótipo , Humanos , Masculino , Mutação , Linhagem , EspanhaRESUMO
Aldolase B is critical for sugar metabolism, and a catalytic deficiency due to mutations in its gene may result in hereditary fructose intolerance (HFI) syndrome, with hypoglycaemia and severe abdominal symptoms. This report describes two cases of HFI, which were identified by intravenous fructose tolerance test and a new RFLP (restriction fragment length polymorphism) test that detects the two most common mutations, A149P and A174D. The method includes PCR of a 224-base-pair segment of exon 5, a subsequent 3 h incubation with Cac8I and agarose electrophoresis, which reveals either or both of the mutations in one single reaction. The method might be useful for screening of these mutations, which may account for more than 70% of the mutations causing HFI.
Assuntos
Análise Mutacional de DNA/métodos , Intolerância à Frutose/enzimologia , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Mutação Puntual , Sequência de Bases , Pré-Escolar , DNA/genética , Éxons , Intolerância à Frutose/diagnóstico , Frutose-Bifosfato Aldolase/deficiência , Testes Genéticos , Humanos , Lactente , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de RestriçãoRESUMO
The diagnosis of HFI is easily missed during childhood. It should be suspected in children presenting with hepatomegaly and an isolated increase in GGT. A carefully taken nutritional history forms the basis of the diagnosis of HFI which can be confirmed by molecular analysis with a sensitivity of > 95%. I.v. fructose tolerance tests and liver biopsies often can be omitted.
Assuntos
Intolerância à Frutose/diagnóstico , Intolerância à Frutose/genética , Frutose-Bifosfato Aldolase/genética , Hepatomegalia/etiologia , Mutação , gama-Glutamiltransferase/sangue , Biópsia , Pré-Escolar , Diagnóstico Diferencial , Intolerância à Frutose/complicações , Intolerância à Frutose/enzimologia , Triagem de Portadores Genéticos , Hepatomegalia/enzimologia , Hepatomegalia/genética , Humanos , Fígado/patologia , MasculinoRESUMO
A molecular analysis of human aldolase B genes in two newborn infants and a 4-year-old child with hereditary fructose intolerance, the offspring of a consanguineous union, has identified the novel mutation Ala337-->Val in homozygous form. This mutation was also detected independently in two other affected individuals who were compound heterozygotes for the prevalent aldolase B allele, Ala149-->Pro, indicating that the mutation causes aldolase B deficiency. To test for the effect of the mutation, catalytically active wild-type human aldolase B and the Val337 variant enzyme were expressed in Escherichia coli. The specific activities of the wild-type recombinant enzyme were 4.8 units/mg and 4.5 units/mg towards fructose 1,6-bisphosphate (FBP) and fructose 1-phosphate (F-1-P) as substrates with Michaelis constants of 4 microM and 2.4 mM respectively. The specific activities of purified tetrameric Val337 aldolase B, which affects an invariant residue in the C-terminal region, were 4.2 units/mg and 2.6 units/mg towards FBP and F-1-P as substrates respectively; the corresponding Michaelis constants were 22 microM and 24 mM. The FBP-to-F-1-P substrate activity ratios were 0.98 and 1.63 for wild-type and Val337 variant enzymes respectively. The Val337 mutant aldolase had an increased susceptibility to proteolytic cleavage in E. coli and rapidly lost activity on storage. Comparative CD determinations showed that the Val337 protein had a distinct thermal denaturation profile with markedly decreased enthalpy, indicating that the mutant protein is partly unfolded. The undegraded mutant had preferentially decreased affinity and activity towards its specific F-1-P substrate and maintained appreciable activity towards FBP. In contrast, fluorescence studies of the mutant showed an increased binding affinity for products of the aldolase reaction, indicating a role for the C-terminus in mediating product release. These findings in a rare but widespread naturally occurring mutant implicate the C-terminus in the activity of human aldolase B towards its specific substrates and demonstrate its role in maintaining the overall stability of the enzyme tetramer.
Assuntos
Substituição de Aminoácidos , Intolerância à Frutose/enzimologia , Frutose-Bifosfato Aldolase/metabolismo , Sítios de Ligação , Catálise , Pré-Escolar , Dicroísmo Circular , Análise Mutacional de DNA , Escherichia coli/genética , Intolerância à Frutose/genética , Intolerância à Frutose/metabolismo , Frutose-Bifosfato Aldolase/química , Frutose-Bifosfato Aldolase/genética , Frutose-Bifosfato Aldolase/isolamento & purificação , Frutosedifosfatos/metabolismo , Frutosefosfatos/metabolismo , Genótipo , Humanos , Recém-Nascido , Cinética , Mutação de Sentido Incorreto/genética , Desnaturação Proteica , Estrutura Secundária de Proteína , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Especificidade por Substrato , Termodinâmica , Trioses/metabolismoRESUMO
We screened the aldolase B gene in 14 unrelated Italian patients with hereditary fructose intolerance (HFI), and found two novel disease related mutations: a single nucleotide deletion in exon 2 (delta A20) that leads to an early stop codon, and a C-->T transition in exon 8 that substitutes an Arg with a Trp residue at codon 303 (R303W).